Yin-Ju Chen
Overview
Explore the profile of Yin-Ju Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
859
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu G, Chen H, Chang C, Chen Y, Wu Y, Widhibrata A, et al.
Biomaterials
. 2025 Mar;
319:123205.
PMID: 40023929
Platelet-derived extracellular vesicles (PEVs) have drawn attention due to their multifunctionality, ease of procurement, and abundant supply from clinical-grade platelet concentrates. PEVs can be readily endocytosed due to their lipid...
2.
Lee Y, Wu S, Wu C, Lin Y, Lin C, Chen Z, et al.
ACS Appl Mater Interfaces
. 2024 Oct;
16(45):61787-61804.
PMID: 39448366
Despite advancements in nanomedicine for drug delivery, many drug-loaded nanoparticles reduce tumor sizes but often fail to prevent metastasis. Mesoporous silica nanoparticles (MSNs) have attracted attention as promising nanocarriers. Here,...
3.
Wu Y, Chao H, Chiang C, Luo Y, Chiu C, Yen S, et al.
Thorac Cancer
. 2023 Jul;
14(25):2591-2600.
PMID: 37474689
Background: Systemic therapy is the primary treatment for advanced thymic malignancies. However, there is an urgent need to improve clinical outcome. Personalized treatment based on predictive biomarkers is a potential...
4.
Huang W, Chen Y, Lee M, Kuo T, Lin M, Lin M
Medicine (Baltimore)
. 2023 Jun;
102(26):e34128.
PMID: 37390292
The coronavirus disease 2019 has become a threat to global healthcare because of its rapid spread and evolution. In severe cases, the initial management of the disease is mainly supportive...
5.
Huang J, Chen S, Liao Y, Kao Y, Ho W, Chang H, et al.
J Pers Med
. 2023 Apr;
13(4).
PMID: 37109054
Twelve Asian patients with sarcoma received interval-compressed (ic-) chemotherapy scheduled every 14 days with a regimen of vincristine (2 mg/m), doxorubicin (75 mg/m), and cyclophosphamide (1200-2200 mg/m) (VDC) alternating with...
6.
Chu Y, Fang H, Wu Y, Tang Y, Hsieh E, She Y, et al.
Int J Nanomedicine
. 2023 Mar;
18:1413-1431.
PMID: 36992821
Background: Corneal neovascularization (NV) is a process of abnormal vessel growth into the transparent cornea from the limbus and can disturb the light passing through the cornea, resulting in vision...
7.
Rethi L, Mutalik C, Rethi L, Chiang W, Lee H, Pan W, et al.
Cancers (Basel)
. 2022 Oct;
14(20).
PMID: 36291827
Near-infrared-photothermal therapy (NIR-PTT) is a potential modality for cancer treatment. Directing photothermal effects specifically to cancer cells may enhance the therapeutic index for the best treatment outcome. While epithelial growth...
8.
Chen Y, Chang R, Fan Y, Yang K, Wang P, Tseng C
Colloids Surf B Biointerfaces
. 2022 Aug;
218:112717.
PMID: 35961109
Surface topography-induced lineage commitment of human bone marrow stem cells (hBMSCs) has been reported. However, this effect on hBMSC differentiation toward retinal pigment epithelium (RPE)-like cells has not been explored....
9.
Wu Y, Hung Y, Chiu N, Lee R, Li C, Chao Y, et al.
Eur J Cancer
. 2022 Mar;
166:208-218.
PMID: 35306319
Introduction: Pancreatic ductal adenocarcinoma (PDAC) is highly aggressive and has poor prognosis. There are few biomarkers to inform treatment decisions, and collecting tumour samples for testing is challenging. Methods: Circulating...
10.
Gbetuwa M, Lu L, Wang T, Chen Y, Chiou J, Su T, et al.
Cells
. 2022 Feb;
11(4).
PMID: 35203275
There has been great interest in identifying the biological substrate for light-cell interaction and their relations to cancer treatment. In this study, a near-infrared (NIR) laser is focused into the...